A 1-year follow-up after a pilot study with Doloteffin® for low back pain

Phytomedicine

Volumn 12, Issue 1-2, 2005, Pages 1-9

  Chrubasik, S ^a,b   Kunzel O ^a   Thanner, J ^a   Conradt, C ^c   Black, A ^d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Harpagophytum extract; Low back pain; One year follow up

Indexed keywords

ANALGESIC AGENT; DOLOTEFFIN; HARPAGOPHYTUM EXTRACT; HARPAGOSIDE; ROFECOXIB;

ABDOMINAL PAIN; ACUTE DISEASE; ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; FOLLOW UP; GALLBLADDER DISEASE; GASTROINTESTINAL SYMPTOM; HEALTH; HUMAN; LEUKOCYTOSIS; LIVER DISEASE; LONG TERM CARE; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MOVEMENT (PHYSIOLOGY); MULTIVARIATE ANALYSIS OF VARIANCE; MUSCULOSKELETAL DISEASE; NAUSEA; NEURALGIA; PAIN ASSESSMENT; PATIENT; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RECORDING; SCORING SYSTEM; SIDE EFFECT; SKIN ALLERGY; SKIN DISEASE;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GLYCOSIDES; HARPAGOPHYTUM; HUMANS; LACTONES; LOW BACK PAIN; MALE; MIDDLE AGED; PAIN MEASUREMENT; PHYTOTHERAPY; PILOT PROJECTS; PLANT EXTRACTS; PYRANS; QUESTIONNAIRES; SULFONES; TREATMENT OUTCOME;

HARPAGOPHYTUM;

EID: 12944323714     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.01.005     Document Type: Article

References (16)

1. G.W. Cannon, J.R. Caldwell, P. Holt, B. McLean, B. Seidenberg, J. Bolognese, E. Ehrich, S. Mukhopadhyay, and B. Daniels Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium Arthritis Rheum. 43 2000 978 987
2. P. Chantre, A. Cappelaere, D. Leblan, D. Guedon, J. Vandermander, and B. Fournie Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis Phytomedicine 7 2000 177 183
3. Chrubasik, S., Schmidt, A., Junck, H., Pfisterer, M., 1997. Wirksamkeit und Wirtschaftlichkeit von Teufelshrallenwurzelextrakt bei Rückenschmerzen: erste Ergebnisse einer Anwendungs-beobachtung. Forsch. Komplementärmed 4, 332-336.
4. S. Chrubasik, H. Junck, H. Breitschwerdt, C. Conradt, and H. Zappe Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain a randomized placebo-controlled double-blind study Eur. J. Anaesthesiol. 16 1999 118 129
5. S. Chrubasik, E. Eisenberg, E. Balan, T. Weinberger, R. Luzzati, and Ch. Conradt Treatment of low back pain exacerbations with willow bark extrakt a randomised double-blind study Am. J. Med. 109 2000 9 14
6. ® in patients with pain in the lower back, knee or hip Phytomedicine 9 2002 181 194
7. ® in the treatment of low back pain Rheumatology 42 2003 141 148
8. S. Chrubasik, C. Conradt, and A. Black The quality of clinical trials with Harpagophytum procumbens Phytomedicine 10 2003 613 623
9. ESCOP Monograph. Harpagophyti radix, 1996. Fascicule 2, ISBN 1-901964-01-9.
10. Fordyce, W.E., 1995. Back Pain in the Workplace. IASP Press, Seattle, pp. 43-46.
11. G.P. Geba, A.L. Weaver, A.B. Polis, M.E. Dixon, and T.J. Schnitzer Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee JAMA 287 2002 64 71
12. N. Katz, W.D. Ju, D.A. Krupa, R.S. Sperling, D.B. Rodgers, B.J. Gertz, J. Gimbel, S. Coleman, C. Fisher, S. Nabizadeh, and D. Borenstein Efficacy and safety of rofecoxib in patients with chronic low back pain Spine 28 2003 851 859
13. B.W. Koes, M.W. van Tulder, R. Ostelo, A.K. Burton, and G. Waddell Clinical guidelines for the management of low back pain in primary care Spine 26 2001 2504 2514
14. J. Lautenschläger, W. Mau, T. Kohlmann, H.H. Raspe, F. Struve, W. Brückle, and H. Zeidler Vergleichende Evaluation einer deutschen Version des Health Assessment Questionnaires (HAQ) und des Funktionsfragebogens Hannover (FFbH) Z. Rheumatol. 56 1997 144 155
15. B. McGuirk, W. King, J. Govind, J. Lowry, and N. Bogduk Safety, efficacy and cost effectiveness of evidence-based guidelines for the management of acute low back pain in primary care Spine 26 2002 2615 2622
16. K. Saag, D. Heijde, C. Fisher, A. Samara, L. DeTora, J. Bolognese, R. Sperling, and B. Daniels Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs Arch. Fam. Med. 9 2000 1124 1134